StocktoriaCardio Diagnostics Holdings, Inc. CDIO
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances
Chart by TradingView
1/9
Piotroski F — financial health
-4.17
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $14,825 | $34,890 | $17,065 | $950 | $901 |
| Operating income | -$6.5M | -$8.4M | -$7.2M | -$4.5M | -$620,448 |
| Net income | -$6.5M | -$8.4M | -$8.4M | -$4.7M | -$620,448 |
| Operating cash flow | -$5.7M | -$5.0M | -$5.7M | -$5.1M | -$585,291 |
| Free cash flow | -$5.9M | -$5.2M | -$6.2M | — | — |
| Total assets | $7.8M | $10.6M | $4.5M | $6.2M | $1.1M |
| Total liabilities | $793,061 | $1.1M | $1.5M | $1.9M | $33,885 |
| Shareholders' equity | $7.0M | $9.6M | $3.0M | $4.3M | $1.1M |
| Ratios | |||||
| Operating margin | -43737.5% | -23977.9% | -42440.4% | -478784.3% | -68862.2% |
| Net margin | -43832.5% | -24028.2% | -49087.8% | -490630.0% | -68862.2% |
| FCF margin | -39893.1% | -14926.5% | -36612.0% | — | — |
| Return on assets | -83.7% | -79.0% | -187.7% | -74.6% | -56.3% |
| Return on equity | -93.2% | -87.7% | -283.2% | -108.4% | -58.1% |
| Current ratio | 9.79 | 13.92 | 3.29 | 3.02 | 6.46 |
| Revenue growth | -57.5% | 104.5% | 1696.3% | 5.4% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 15,348 | $29,929 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -4.17 (distress)
- Working capital / assets 0.684
- Retained earnings / assets -3.766
- EBIT / assets -0.835
- Equity / liabilities 8.793
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001870144 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.